Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
@yasiralkhalili.bsky.social
Associate Director, Georgetown & NIH Adult Neurology Residency Program
Director, MedStar FSMC ALS Center
Director, AANEM Accr. MWHC EMG Lab
Clerkship Director, NEUR 502 Neuromuscular Elective
Associate Professor - Georgetown University
Director, MedStar FSMC ALS Center
Director, AANEM Accr. MWHC EMG Lab
Clerkship Director, NEUR 502 Neuromuscular Elective
Associate Professor - Georgetown University
Reposted by Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
The timing of neurology fellowship application does pose a fixable conundrum for residents and programs. @aanmember.bsky.social @greenjournal.bsky.social
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
December 4, 2024 at 5:45 PM
The timing of neurology fellowship application does pose a fixable conundrum for residents and programs. @aanmember.bsky.social @greenjournal.bsky.social
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
Reposted by Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
The Neurology Podcast Recall
🎙️ for December 2024
showcases five episodes on the topic of Autoimmune Neurology.
#MedSky 🧠 #NeuroSky 🧪
Listen now: bit.ly/498QcvE
🎙️ for December 2024
showcases five episodes on the topic of Autoimmune Neurology.
#MedSky 🧠 #NeuroSky 🧪
Listen now: bit.ly/498QcvE
December 2024 Recall: Topics in Autoimmune Neurology
The December 2024 replay wraps up the year with five previously posted episodes on autoimmune neurology. The episode begins with Drs. Michael R. Wilson and John Pluvinage discussing transcobalamin ant...
bit.ly
December 2, 2024 at 11:25 PM
The Neurology Podcast Recall
🎙️ for December 2024
showcases five episodes on the topic of Autoimmune Neurology.
#MedSky 🧠 #NeuroSky 🧪
Listen now: bit.ly/498QcvE
🎙️ for December 2024
showcases five episodes on the topic of Autoimmune Neurology.
#MedSky 🧠 #NeuroSky 🧪
Listen now: bit.ly/498QcvE
Reposted by Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
December 6, 2024 at 3:44 AM
Reposted by Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
Reposted by Yasir Al-Khalili MD MSEd MBA FAAN د. ياسِر عبْد ألهَادِي ألخَليّـلِي
New #schizophrenia drug could treat #Alzheimers disease: half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.
#dementia #mentalhealth #geriatrics #psychiatry #neurology #neuroscience
#dementia #mentalhealth #geriatrics #psychiatry #neurology #neuroscience
New schizophrenia drug could treat Alzheimer’s disease
Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.
www.nature.com
November 30, 2024 at 1:32 AM
New #schizophrenia drug could treat #Alzheimers disease: half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.
#dementia #mentalhealth #geriatrics #psychiatry #neurology #neuroscience
#dementia #mentalhealth #geriatrics #psychiatry #neurology #neuroscience